GlassScriptPhysician profile
Mona Carol Mccullough
NPI 1437348422
$3,449.27
in general payments reported to CMS, 2019-2025
20 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,350 · 2021: $44.51 · 2022: $158 · 2023: $570 · 2024: $71.36 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.33 |
| Education | $123.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,205.50 | 2019 | |
| Medtronic, INC. | $311.22 | 2021-2025 | Interstim |
| Stryker Corporation | $287.10 | 2019-2023 | Mako |
| Caldera Medical, INC | $88.75 | 2023 | Desara |
| Astellas Pharma US INC | $84.99 | 2023 | |
| Axonics, INC. | $67.43 | 2022-2023 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $54.07 | 2023-2024 | Gemtesa |
| Integra Lifesciences Corporation | $45.06 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Urovant Sciences INC | $43.00 | 2022 | |
| Pfizer INC. | $36.74 | 2023 | |
| Coastal Medical Technologies LLC | $35.46 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.35 | 2023 | |
| Dentsply Ih Ab | $28.31 | 2023-2025 | Lofric, Lofric |
| Actelion Pharmaceuticals US, INC. | $23.83 | 2025 | Opsumit |
| Insulet Corporation | $23.62 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $22.35 | 2024 | Maci |
| Boston Scientific Corporation | $17.45 | 2025 | Wavewriter Alpha Prime 16 |
| Hologic Sales and Service, LLC | $16.57 | 2023 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Novo Nordisk INC | $16.23 | 2023 | Wegovy |
| Allergan, INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Mccullough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.